hepatoma
Showing 1 - 24 of 24
Carcinoma, Hepatocellular, Hepatoma Trial in Seongnam, Seoul (Regorafenib/Nivolumab)
Completed
- Carcinoma, Hepatocellular
- Hepatoma
-
Seongnam, Korea, Republic of
- +2 more
Dec 4, 2022
Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Worldwide (Nivolumab, Relatlimab)
Recruiting
- Hepatocellular Carcinoma
- +4 more
- Nivolumab
- Relatlimab
-
Ciudad de Buenos Aires, Buenos Aires, Argentina
- +74 more
Nov 11, 2022
Liver Cancer, Hepatoma Trial (Yttrium 90 (TheraSphere))
Completed
- Liver Cancer
- Hepatoma
- Yttrium 90 (TheraSphere)
- (no location specified)
Sep 28, 2022
Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Charlotte (Transarterial embolization, Microwave Ablation)
Terminated
- Hepatocellular Carcinoma
- +4 more
- Transarterial embolization
- Microwave Ablation
-
Charlotte, North CarolinaCarolinas Medical Center
Apr 20, 2022
Hepatocellular Carcinoma, Hepatoma Trial in Baltimore (sorafenib, LC Bead-TACE)
Completed
- Hepatocellular Carcinoma
- Hepatoma
- sorafenib
- LC Bead-TACE
-
Baltimore, MarylandThe Johns Hopkins Hospital
Oct 15, 2021
Hepatocellular Carcinoma, Liver Cancer, Hepatoma Trial in New York (Bead Block microspheres, Bead + Dox Arm)
Active, not recruiting
- Hepatocellular Carcinoma
- +2 more
- Bead Block microspheres
- Bead + Dox Arm
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 30, 2021
Hepatoma, Pancreas Cancer Trial in Bangkok Noi (Thoracic continuous epidural analgesia)
Recruiting
- Hepatoma
- Pancreas Cancer
- Thoracic continuous epidural analgesia
-
Bangkok Noi, Bangkok, ThailandFaculty of Medicine Siriraj Hospital, Mahidol University
Jun 8, 2021
Unresectable Hepatocellular Carcinoma With TheraSphere®
Completed
- Liver Tumors
- +3 more
- TheraSphere®
-
Orange, CaliforniaThe Center for Cancer Prevention & Treatment at St. Joseph Hospi
Apr 1, 2021
Hepatocellular Carcinoma, Hepatoma, Liver Cell Carcinoma Trial in United States (DEB-TACE, Sorafenib)
Terminated
- Hepatocellular Carcinoma
- +2 more
- DEB-TACE
- Sorafenib
-
Birmingham, Alabama
- +5 more
Jan 25, 2021
Esophagus Cancer, Hepatoma, Glioma Trial in Zhengzhou (CAR-T/TCR-T cells immunotherapy)
Unknown status
- Esophagus Cancer
- +3 more
- CAR-T/TCR-T cells immunotherapy
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Feb 3, 2021
Carcinoma, Hepatocellular, Hepatoma Trial in United States (SIR-Spheres microspheres)
Terminated
- Carcinoma, Hepatocellular
- Hepatoma
- SIR-Spheres microspheres
-
Philadelphia, Pennsylvania
- +3 more
Nov 16, 2020
Hepatocellular Carcinoma, Hepatoma, Liver Cell Carcinoma Trial (Elbasvir / Grazoprevir Oral Tablet)
Withdrawn
- Hepatocellular Carcinoma
- +3 more
- Elbasvir / Grazoprevir Oral Tablet
- (no location specified)
Sep 6, 2020
Cancer of the Liver, Liver Cancer, Hepatoma Trial in Minneapolis (Salmonella typhimurium)
Completed
- Cancer of the Liver
- +4 more
- Salmonella typhimurium
-
Minneapolis, MinnesotaEdward W. Greeno, MD
Jul 6, 2020
B-cell Acute Lymphoblastic Leukemia, Lymphoma, Myeloid Leukemia Trial in Zhengzhou (CAR-T cell immunotherapy)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +15 more
- CAR-T cell immunotherapy
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Dec 10, 2019
Hepatoma, Liver Tumors, Adenoma, Liver Cell Trial run by the NCI (TRC 105, Sorafenib)
Completed
- Hepatoma
- +4 more
- TRC 105
- Sorafenib
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 2, 2019
Hepatoma, Advanced Solid Tumor Trial in New York (irinotecan and ON 01910.Na, oxaliplatin and ON 01910.Na)
Completed
- Hepatoma
- Advanced Solid Tumor
- irinotecan and ON 01910.Na
- oxaliplatin and ON 01910.Na
-
New York, New YorkMount Sinai Medical Center
Jun 22, 2017
Hepatocellular Carcinoma, Hepatoma, Cholangiocarcinoma Trial in Tokyo (Sevoflurane, Desflurane)
Unknown status
- Hepatocellular Carcinoma
- +3 more
-
Tokyo, JapanTokyo Medical and Dental University
Apr 20, 2016
Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Los Angeles, Pittsburgh (AFP + GM-CSF Plasmid Prime and AFP
Terminated
- Hepatocellular Carcinoma
- +13 more
- AFP + GM-CSF Plasmid Prime and AFP Adenoviral Vector Boost
-
Los Angeles, California
- +1 more
Dec 1, 2015
Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatoma Trial in Milwaukee (Sorafenib, Conventional fractionation (2 Gy per
Withdrawn
- Hepatocellular Carcinoma
- +3 more
- Sorafenib
- Conventional fractionation (2 Gy per day) external beam radiation therapy
-
Milwaukee, WisconsinFroedtert Memorial Lutheran Hospital
Sep 4, 2013
Hepatoma, Cinobufacin Injection Trial in Shanghai (Cinobufacin injection)
Unknown status
- Hepatoma
- Cinobufacin Injection
- Cinobufacin injection
-
Shanghai, Shanghai, ChinaDepartment of TCM, Changhai Hospital of Shanghai
Jun 27, 2011
Liver Cirrhosis, Hepatoma Trial in Taipei city (propranolol)
Unknown status
- Liver Cirrhosis
- Hepatoma
-
Taipei city, TaiwanVeteran General Hospital-Taipei
Jun 14, 2011
Hepatocellular Carcinoma, Hepatoma, Cholangiocarcinoma Trial in Temple (Endoscopy ultrasound)
Unknown status
- Hepatocellular Carcinoma
- +3 more
- Endoscopy ultrasound
-
Temple, TexasCentral Texas Veterans health Care System
Jun 5, 2006